Getting a supplement ad account suspended is more common than most brands expect, and less recoverable than most assume. Google can suspend an account with 24 hours' notice. Meta can restrict an account permanently after repeated violations. In both cases, the most common cause is the same: health claims that the platform cannot verify.

This is not primarily a technical problem. It is an evidence problem. And it has a direct solution.

Why accounts get flagged

Both Google and Meta use automated systems that scan ad copy, landing pages, and linked websites for health claim language. These systems are not subtle. They flag on keywords, sentence patterns, and combinations of product category plus health outcome language.

Common triggers include:

When a flag occurs, it triggers one of three outcomes: the ad is rejected; the account is restricted; or the account is suspended. The distinction matters because each requires a different response.

What Google requires

Google's primary policies for supplement brands sit under Healthcare and Medicines and Misleading Representation. The Healthcare and Medicines policy places supplements in a "restricted" category, meaning they can be advertised but only with compliant claims and, in some markets, with a verified advertiser status.

For health claims specifically, Google requires that claims are "accurate and substantiated." In practical terms, this means:

Google's automated systems flag accounts; manual review teams then assess them. During a manual review, Google may request documentation of your claims. A published peer-reviewed study specific to your product is the most credible documentation you can provide.

What Meta requires

Meta's advertising policies for health products prohibit ads that "exaggerate the effectiveness" of products or imply they can prevent or treat disease. Meta also specifically restricts:

Meta's enforcement is largely automated and inconsistently applied. Accounts in good standing with longer advertising histories are treated differently to newer accounts. The practical implication: consistent, evidenced, conservative claims from the start build an account track record that provides more resilience against automated flags than aggressive copy that pushes policy limits.

The brands that run the most successful supplement ads on Google and Meta are not the ones that push policy boundaries. They are the ones whose claims are so well-evidenced that they have nothing to worry about in a manual review.

Nathan Phillips, CEO, StudySetGo

How clinical evidence changes your position

Published clinical evidence does three things for your advertising account:

1. It unlocks specific, credible claim language

Without evidence, your claims are limited to generic function language that every competitor in your category can also use. With a published study, you can say "shown in a 12-week clinical study to improve X." That claim is specific, credible, and differentiating. It is also less likely to trigger automated flags than vague superlatives, because it references a verifiable source.

2. It gives you a substantiation document for manual review

When Google or Meta puts your account into manual review, the question is: can you substantiate the claims in your ads? A published peer-reviewed study is the strongest possible answer. Generic ingredient studies, white papers, or internal data carry significantly less weight. The study needs to match the claims: if you are claiming your formula improves cognitive function, the study needs to be on your formula, not on one ingredient in isolation.

3. It reduces the most common reason for account suspension

Accounts get suspended for making claims they cannot support. If your claims are directly referenced to a published study, the risk of a successful complaint or a sustained suspension is materially lower. This is not guaranteed protection, but it is the most practical risk reduction available to supplement brands in paid advertising.

What to do after a suspension

If your account is already suspended:

  1. Audit every health claim on your website and ad copy. Remove anything that implies disease treatment or prevention.
  2. Submit an appeal with a clear explanation of the changes made and, if you have it, supporting documentation for remaining claims.
  3. If your appeal is rejected, do not create a new account on the same domain. This typically accelerates a permanent ban.
  4. For Google specifically, the advertiser verification programme exists for healthcare advertisers and can provide a route back to advertising after compliance is demonstrated.

Getting evidence in place before relaunching ads is the most reliable way to avoid the same outcome. See our guide to getting clinical evidence for a step-by-step overview of the process.

Frequently asked questions

The most common cause is health claims in ad copy or on the landing page that imply disease treatment or prevention, or that the platform cannot verify. Google flags accounts via automated systems and escalates repeat violations to suspension. The fix involves removing non-compliant claims, substantiating remaining claims with published evidence, and submitting an appeal.

Google requires claims to be "accurate and substantiated." For efficacy claims, a published peer-reviewed clinical study specific to your product is the strongest form of substantiation. Third-party ingredient studies are generally not sufficient for claims about your specific formula. Disease claims (treating or preventing specific conditions) are prohibited regardless of evidence.

Clinical evidence allows you to make specific, referenced claims ("shown in a published study to...") rather than unsubstantiated superlatives. Referenced claims are less likely to trigger Meta's automated content flags and provide a credible substantiation document if an ad enters manual review. Meta's policies prohibit exaggerated efficacy claims and disease prevention claims, but support function claims backed by evidence.

Yes. A published peer-reviewed study that matches the specific claims in your ads is a meaningful input during a manual review or appeal. Both platforms have substantiation review processes. The study must be specific to the claims you are making: a third-party study on a single ingredient is generally not sufficient if the claim refers to your full formula.